Table 1.
Clinicopathological characteristics of HER2+ BC patients.
| Characteristics | HER2+ BC Patients |
|---|---|
| Number | 33 |
| Median age in years (range) | 51.5 (35–70) |
| HR | |
| HR+ | 17 (51.52%) |
| HR− | 16 (48.48%) |
| Stage, N (%) | |
| I | 3 (9.09%) |
| II | 23 (69.70%) |
| III | 6 (18.18%) |
| IV | 1 (3.03%) |
| Grade | |
| II | 11 (33.33%) |
| III | 21 (63.64%) |
| NA | 1 (3.03%) |
| Treatment | |
| Adjuvant | 18 (54.55%) |
| Neoadjuvant | 15 (45.45%) |
| Response | |
| Disease-free | 13 (39.40%) |
| Relapsed | 20 (60.60%) |
| Median follow up (months) | 97 |
| Median DFS | 49 (6–177) |
| Median OS | 96 (7–177) |
NA: Not available.